Sign in

CIK 0000943819 · Large accelerated filer

RESMED INC

Sign in to watch
Tickers
RMD RSMDF
Exchange
NYSE, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
980152841
Phone
8587462400
Business address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123

Securities

  • RMD ResMed Inc. Common Stock NYSE
  • RSMDF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,744,605
in 5 filings, $3.7M under 10b5-1 plans

Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Farrell Michael J. −$3.4M Chairman and CEO sold 3% of stake
  2. FARRELL PETER C −$228K Director sold 2% of stake
  3. Rider Michael J −$102K Global General Counsel sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-13 Farrell Michael J. Chief Executive Officer Shares withheld for taxes −3,037.91 $143.60 $436K 443,167
2023-11-13 Farrell Michael J. Chief Executive Officer Shares withheld for taxes −2,181.29 $143.60 $313K 440,986
2023-11-13 BLAISE LUCILE President, Sleep & RC Business Shares withheld for taxes −135.35 $143.60 $19K 10,305
2023-11-13 FARRELL PETER C Director Shares withheld for taxes −325.38 $143.60 $47K 179,171
2023-11-13 Gill Harjit Director Shares withheld for taxes −79.2 $143.60 $11K 7,187
2023-11-01 Rider Michael J Global General Counsel Sale 10b5-1 −25 $143.42 $4K 7,358
2023-10-16 Farrell Michael J. Chief Executive Officer Option exercise 10b5-1 +5,675 $57.76 $328K 455,035
2023-10-16 Farrell Michael J. Chief Executive Officer Sale 10b5-1 −5,675 $140.70 $798K 449,360
2023-10-16 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options 10b5-1 −5,675 9,140
2023-10-02 Rider Michael J Global General Counsel Sale 10b5-1 −25 $145.92 $4K 7,383
2023-09-15 Farrell Michael J. Chief Executive Officer Option exercise 10b5-1 +5,675 $57.76 $328K 455,035
2023-09-15 Farrell Michael J. Chief Executive Officer Sale 10b5-1 −5,675 $146.35 $831K 449,360
2023-09-15 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options 10b5-1 −5,675 14,815
2023-09-01 Rider Michael J Global General Counsel Sale 10b5-1 −25 $161.15 $4K 7,408
2023-08-25 BLAISE LUCILE President, Sleep & RC Business Shares withheld for taxes −379.69 $165.67 $63K 10,355
2023-08-17 Rider Michael J Global General Counsel Grant or award +2,247 7,433
2023-08-17 BLAISE LUCILE President, Sleep & RC Business Grant or award +819 7,441
2023-08-17 BLAISE LUCILE President, Sleep & RC Business Grant or award +3,294 10,735
2023-08-17 Ghoshal Kaushik President, SaaS Business Grant or award +2,486 14,273
2023-05-03 FARRELL PETER C Director Sale −12,600 $237.17 $3.0M 166,896

Page 18 of 18 · 360 trades